Keskindemirci G, Aktay-Ayaz N, Melikoğlu N, Bornaun H, Aydoğmuş Ç, Aldemir E, Aydoğan G. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome and coronary artery dilatation misdiagnosed as Kawasaki disease. Turk J Pediatr 2015; 57: 518-521.Systemic onset juvenile idiopathic arthritis (SoJIA) is characterized by arthritis, fever and visceral organ involvement including hepatosplenomegaly, lympadenopathy and serositis. This is a case of SoJIA misdiagnosed as Kawasaki disease (KD) and developed machrophage activation syndrome (MAS) secondary to Ebstein-Barr virus (EBV) infection. It is presented to point out the conditions that may come along. First of all, SoJIA should be kept in mind while making the differential diagnosis of coronary arterial ectasias and dilatations usually seen in vasculitic diseases like KD. Second, as a very fatal complication MAS should always be considered while following a patient with the diagnosis of SoJIA. Infections like EBV may be the potential triggers for development of MAS especially in immunesupressed patients
___
1. Angelo Ravelli. Macrophage activation syndrome Curr Opin Rheumatol 2002; 14: 548-552.
2. Binstadt BA, Levine JC, Nigrovic PA, et al. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics 2005; 116: 89-93.
3. Kumar S, Vaidyanathan B, Gayathri S, et al. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review. Rheumatol Int 2013; 33: 1065-1069.
4. Newburger JW, Takahashi M, Gerber MA, et al. Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004; 114: 1708-1733.
5. Rowley, AH. Incomplete (atypical) Kawasaki disease Pediatr Infect Dis J 2002; 6: 563-565.
6. Dogra S, Gehlot A, Suri D, Rawat A, Kumar RM, Singh S. Incomplete Kawasaki disease followed by systemic onset juvenile idiopathic arthritis - the diagnostic dilemma. Indian J Pediatr 2013; 80: 783-785.
7. Petty RE, Southwood TR, Manners P, et al. Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision. Edmonton, 2001. J Rheumatol 2004; 31: 390-392.
8. Dajani A S, Taubert K A, Gerber M A, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993; 87: 1776-1780.
9. Canna SW, Behrens EM. Making sense of the cytokine storm:a conceptual framework for understanding, diagnosing and treating hempphagocytic syndromes. Pediatr Clin North Am 2012; 59: 339-344.
10. Nigrovic PA. Review: Is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis. Arthritis Rheumatol 2014; 66: 1405-1413.
11. Nogueira MV, Vidal L, Terra B, et al. Hemophagocytic syndrome associtaed with cytomegalovirus infection in a severely immunocompromised AIDS patient:case report. Braz J Infect Dis 2009; 13: 72-73.
12. Ravelli A, De Benedetti F, Viola S, et al. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996; 128: 275-278.
13. Stéphan JL , Koné-Paut I, Galambrun C, et al. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 2001; 40: 1285-1292.
14. Kostik M, Snegireva L, Dubko M, et al. Rescue Treatment by Increased Doses of IL-1 Inhibitors for Macrophage Activation Syndrome in Children With Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol 2014; 11: 133.